Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a transition program to reduce disability in people recovering from stroke

Compares a stroke education program with an environmental modifications program in adults 55 and older.

Plain-language title generated from the registry record
Registry title: Compass 3: A Novel Transition Program to Reduce Disability After Stroke

Key facts

Where
Columbia and St Louis, United StatesSee the 2 sites

Where in United States

  • University of MissouriColumbia, United StatesNot yet recruiting
  • Washington University in St. LouisSt Louis, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Washington University School of Medicine
Trial code
NCT07069660
Record updated
13 February 2026
Original description
This study evaluates a program designed to help individuals transition from inpatient rehabilitation to home following an ischemic or hemorrhagic stroke. Half of the participants will receive a stroke education program while the other half will receive an environmental modifications program.Read full original descriptionShow less

Compass 3: A Novel Transition Program to Reduce Disability After a Stroke

This study evaluates a program designed to help individuals transition from inpatient rehabilitation to home following an ischemic or hemorrhagic stroke. Half of the participants will receive a stroke education program while the other half will receive an environmental modifications program.

Inclusion: Aged ≥55 years at the time of screening; Acute stroke diagnosis (IS or ICH) verified by the stroke team or medical record; Independent in activities of daily living (ADLs) prior to stroke (premorbid Modified Rankin Scale score ≤2); Plan to discharge to home from an IR; Capable of giving informed consent which includes compliance with the requirements and duration of participation as listed in the Informed Consent Form (ICF).

Exclusion: Cognitive impairment that the participant's stroke team or a research team member believes impairs their ability to provide informed consent or make reasoned choice including the interpretation of the self-rated scales; Life expectancy <6 months; Any communication problem that would prevent study completion; Residence in a congregate living facility; Not eligible for a therapeutic pass; Residence outside of the designated catchment area (specific catchment distance to be determined by each site); Site investigator's judgment that the participant would not be able to complete research procedures or interventions; Participation in another research study that in the site investigator's judgment could interfere or conflict with this research study's assessments or interventions.

ClinicalTrials.gov NCT07069660